- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/12 - Radicals substituted by halogen atoms or nitro or nitroso radicals
Patent holdings for IPC class C07D 333/12
Total number of patents in this class: 85
10-year publication summary
|
3
|
4
|
6
|
6
|
1
|
3
|
5
|
1
|
5
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5772 |
4 |
| Lonza Ltd. | 595 |
4 |
| Osaka University | 3254 |
4 |
| Solutia Canada Inc | 44 |
4 |
| Arxada AG | 68 |
4 |
| Janssen Pharmaceutica N.V. | 3125 |
3 |
| Daikin Industries, Ltd. | 10546 |
3 |
| Mitsubishi Tanabe Pharma Corporation | 387 |
3 |
| SCI Pharmtech, Inc. | 16 |
3 |
| BASF SE | 21339 |
2 |
| Boehringer Ingelheim Vetmedica GmbH | 1271 |
2 |
| Syngenta Participations AG | 1472 |
2 |
| Shanghai Syncores Technologies Inc. Ltd | 36 |
2 |
| Tokuyama Corporation | 1508 |
2 |
| Zhejiang Huahai Pharmaceutical Co., Ltd. | 219 |
2 |
| Glaxosmithkline LLC | 525 |
1 |
| Bayer Cropscience AG | 1817 |
1 |
| Samsung SDI Co., Ltd. | 11065 |
1 |
| Sumitomo Chemical Company, Limited | 8992 |
1 |
| Agency for Science, Technology and Research | 3786 |
1 |
| Other owners | 36 |